These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 27456702)

  • 1. Fingolimod: A Disease-Modifier Drug in a Mouse Model of Amyotrophic Lateral Sclerosis.
    Potenza RL; De Simone R; Armida M; Mazziotti V; Pèzzola A; Popoli P; Minghetti L
    Neurotherapeutics; 2016 Oct; 13(4):918-927. PubMed ID: 27456702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microglia and motor neurons during disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis: changes in arginase1 and inducible nitric oxide synthase.
    Lewis KE; Rasmussen AL; Bennett W; King A; West AK; Chung RS; Chuah MI
    J Neuroinflammation; 2014 Mar; 11():55. PubMed ID: 24655927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model.
    Li Y; Guo Y; Wang X; Yu X; Duan W; Hong K; Wang J; Han H; Li C
    Neuroscience; 2015 Jul; 298():12-25. PubMed ID: 25841320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inducible nitric oxide synthase is present in motor neuron mitochondria and Schwann cells and contributes to disease mechanisms in ALS mice.
    Chen K; Northington FJ; Martin LJ
    Brain Struct Funct; 2010 Mar; 214(2-3):219-34. PubMed ID: 19888600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis.
    Almer G; Vukosavic S; Romero N; Przedborski S
    J Neurochem; 1999 Jun; 72(6):2415-25. PubMed ID: 10349851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic Administration of Pimozide Fails to Attenuate Motor and Pathological Deficits in Two Mouse Models of Amyotrophic Lateral Sclerosis.
    Pozzi S; Thammisetty SS; Julien JP
    Neurotherapeutics; 2018 Jul; 15(3):715-727. PubMed ID: 29790082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C/EBPβ expression in activated microglia in amyotrophic lateral sclerosis.
    Valente T; Mancera P; Tusell JM; Serratosa J; Saura J
    Neurobiol Aging; 2012 Sep; 33(9):2186-99. PubMed ID: 22015310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
    Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of rosmarinic acid in motor dysfunction and life span in a mouse model of familial amyotrophic lateral sclerosis.
    Shimojo Y; Kosaka K; Noda Y; Shimizu T; Shirasawa T
    J Neurosci Res; 2010 Mar; 88(4):896-904. PubMed ID: 19798750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of Withania somnifera extract in SOD1
    Dutta K; Patel P; Julien JP
    Exp Neurol; 2018 Nov; 309():193-204. PubMed ID: 30134145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis.
    Beers DR; Henkel JS; Zhao W; Wang J; Huang A; Wen S; Liao B; Appel SH
    Brain; 2011 May; 134(Pt 5):1293-314. PubMed ID: 21596768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deleterious effects of lymphocytes at the early stage of neurodegeneration in an animal model of amyotrophic lateral sclerosis.
    Tada S; Okuno T; Yasui T; Nakatsuji Y; Sugimoto T; Kikutani H; Sakoda S
    J Neuroinflammation; 2011 Feb; 8():19. PubMed ID: 21345177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal cord pathology is ameliorated by P2X7 antagonism in a SOD1-mutant mouse model of amyotrophic lateral sclerosis.
    Apolloni S; Amadio S; Parisi C; Matteucci A; Potenza RL; Armida M; Popoli P; D'Ambrosi N; Volonté C
    Dis Model Mech; 2014 Sep; 7(9):1101-9. PubMed ID: 25038061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of toll-like receptor 4 (TLR4) extends survival in the hSOD1 G93A mouse model of amyotrophic lateral sclerosis.
    Lee JY; Lee JD; Phipps S; Noakes PG; Woodruff TM
    J Neuroinflammation; 2015 May; 12():90. PubMed ID: 25962427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
    Apolloni S; Amadio S; Montilli C; Volonté C; D'Ambrosi N
    Hum Mol Genet; 2013 Oct; 22(20):4102-16. PubMed ID: 23736299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis.
    Ahn SW; Jeon GS; Kim MJ; Shon JH; Kim JE; Shin JY; Kim SM; Kim SH; Ye IH; Lee KW; Hong YH; Sung JJ
    J Neurol Sci; 2014 May; 340(1-2):112-6. PubMed ID: 24680562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression.
    Apolloni S; Fabbrizio P; Amadio S; Volonté C
    J Neuroinflammation; 2016 Aug; 13(1):191. PubMed ID: 27549088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bromocriptine methylate suppresses glial inflammation and moderates disease progression in a mouse model of amyotrophic lateral sclerosis.
    Tanaka K; Kanno T; Yanagisawa Y; Yasutake K; Hadano S; Yoshii F; Ikeda JE
    Exp Neurol; 2011 Nov; 232(1):41-52. PubMed ID: 21867702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. System xC- is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice.
    Mesci P; Zaïdi S; Lobsiger CS; Millecamps S; Escartin C; Seilhean D; Sato H; Mallat M; Boillée S
    Brain; 2015 Jan; 138(Pt 1):53-68. PubMed ID: 25384799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clemastine Confers Neuroprotection and Induces an Anti-Inflammatory Phenotype in SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis.
    Apolloni S; Fabbrizio P; Parisi C; Amadio S; Volonté C
    Mol Neurobiol; 2016 Jan; 53(1):518-531. PubMed ID: 25482048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.